Literature DB >> 23165261

Down syndrome: the brain in trisomic mode.

Mara Dierssen1.   

Abstract

Down syndrome is the most common form of intellectual disability and results from one of the most complex genetic perturbations that is compatible with survival, trisomy 21. The study of brain dysfunction in this disorder has largely been based on a gene discovery approach, but we are now moving into an era of functional genome exploration, in which the effects of individual genes are being studied alongside the effects of deregulated non-coding genetic elements and epigenetic influences. Also, new data from functional neuroimaging studies are challenging our views of the cognitive phenotypes associated with Down syndrome and their pathophysiological correlates. These advances hold promise for the development of treatments for intellectual disability.

Entities:  

Mesh:

Year:  2012        PMID: 23165261     DOI: 10.1038/nrn3314

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  175 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome.

Authors:  Carmen Martínez-Cué; Carmela Baamonde; Marian Lumbreras; Jesús Paz; Muriel T Davisson; Cecilia Schmidt; Mara Dierssen; Jesús Flórez
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

3.  Neuropsychological correlates of word identification in Down syndrome.

Authors:  Deborah J Fidler; David E Most; Mark M Guiberson
Journal:  Res Dev Disabil       Date:  2005 Sep-Oct

4.  Phonological similarity and lexicality effects in children's verbal short-term memory: concerns about the interpretation of probed recall data.

Authors:  Christopher Jarrold; Joanne Cocksey; Emma Dockerill
Journal:  Q J Exp Psychol (Hove)       Date:  2008-02       Impact factor: 2.143

5.  Exploring the forgetting mechanisms in working memory: evidence from a reasoning span test.

Authors:  Satoru Saito; Christopher Jarrold; Deborah M Riby
Journal:  Q J Exp Psychol (Hove)       Date:  2008-12-03       Impact factor: 2.143

6.  Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.

Authors:  Noemí Rueda; María Llorens-Martín; Jesús Flórez; Elsa Valdizán; Pradeep Banerjee; Jose Luis Trejo; Carmen Martínez-Cué
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.

Authors:  Lisa E Olson; Randall J Roper; Crystal L Sengstaken; Elizabeth A Peterson; Veronica Aquino; Zygmunt Galdzicki; Richard Siarey; Mikhail Pletnikov; Timothy H Moran; Roger H Reeves
Journal:  Hum Mol Genet       Date:  2007-03-05       Impact factor: 6.150

Review 8.  Functional genomics of Down syndrome: a multidisciplinary approach.

Authors:  M Dierssen; E Martí; C Pucharcós; V Fotaki; X Altafaj; K Casas; A Solans; M L Arbonés; C Fillat; X Estivill
Journal:  J Neural Transm Suppl       Date:  2001

9.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

10.  Meiotic behavior of aneuploid chromatin in mouse models of Down syndrome.

Authors:  Laura G Reinholdt; Anne Czechanski; Sonya Kamdar; Benjamin L King; Fengyun Sun; Mary Ann Handel
Journal:  Chromosoma       Date:  2009-07-29       Impact factor: 4.316

View more
  91 in total

1.  Three-Dimensional Hyaluronic Acid Hydrogel-Based Models for In Vitro Human iPSC-Derived NPC Culture and Differentiation.

Authors:  Shaohua Wu; Ranjie Xu; Bin Duan; Peng Jiang
Journal:  J Mater Chem B       Date:  2017-04-19       Impact factor: 6.331

2.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

Review 3.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

Review 4.  Impact of DNA repair and stability defects on cortical development.

Authors:  Federico T Bianchi; Gaia E Berto; Ferdinando Di Cunto
Journal:  Cell Mol Life Sci       Date:  2018-08-16       Impact factor: 9.261

5.  Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

Authors:  J London; F K Ndiaye; L C Bui; B Souchet; F Daubigney; C Magnan; S Luquet; J Dairou; N Janel; C Rouch
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

6.  Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Jessica Yu; Jeesun Kim; Larisa V Lysenko; Zheng Zeng; Y Eugene Yu; William C Mobley
Journal:  Neurobiol Dis       Date:  2017-03-22       Impact factor: 5.996

7.  Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.

Authors:  Akiko Nakano-Kobayashi; Tomonari Awaya; Isao Kii; Yuto Sumida; Yukiko Okuno; Suguru Yoshida; Tomoe Sumida; Haruhisa Inoue; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

8.  Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings.

Authors:  Sandra Giménez; Laura Videla; Sergio Romero; Bessy Benejam; Susana Clos; Susana Fernández; Maribel Martínez; Maria Carmona-Iragui; Rosa M Antonijoan; Mercedes Mayos; Ana Fortuna; Patricia Peñacoba; Vicente Plaza; Ricardo S Osorio; Ram A Sharma; Ignasi Bardés; Anne-Sophie Rebillat; Alberto Lleó; Rafael Blesa; Sebastian Videla; Juan Fortea
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

9.  Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.

Authors:  Alex M Helman; Morgan Siever; Katie L McCarty; Ira T Lott; Eric Doran; Erin L Abner; Frederick A Schmitt; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

10.  Lessons from individuals with Down syndrome during COVID-19.

Authors:  María Del Carmen Ortega; José M Borrel; Teresa de Jesús Bermejo; Domingo González-Lamuño; Coral Manso; Rafael de la Torre; Miguel-Angel Mayer; Diego Real de Asúa; Mara Dierssen
Journal:  Lancet Neurol       Date:  2020-12       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.